265 related articles for article (PubMed ID: 33711180)
1. Randomised study: effects of the 5-HT
Chedid V; Brandler J; Arndt K; Vijayvargiya P; Wang XJ; Burton D; Harmsen WS; Siegelman J; Chen C; Chen Y; Almansa C; Dukes G; Camilleri M
Aliment Pharmacol Ther; 2021 May; 53(9):1010-1020. PubMed ID: 33711180
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
4. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
[TBL] [Abstract][Full Text] [Related]
5. Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 study.
Kuo B; Barnes CN; Nguyen DD; Shaywitz D; Grimaldi M; Renzulli C; Canafax D; Parkman HP
Aliment Pharmacol Ther; 2021 May; 53(10):1090-1097. PubMed ID: 33811761
[TBL] [Abstract][Full Text] [Related]
6. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
[TBL] [Abstract][Full Text] [Related]
7. Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.
Parkman HP; Sharkey E; McCallum RW; Hasler WL; Koch KL; Sarosiek I; Abell TL; Kuo B; Shulman RJ; Grover M; Farrugia G; Schey R; Tonascia J; Hamilton F; Pasricha PJ;
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):546-558.e5. PubMed ID: 33130007
[TBL] [Abstract][Full Text] [Related]
8. Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected Gastroparesis.
Lee AA; Rao S; Nguyen LA; Moshiree B; Sarosiek I; Schulman MI; Wo JM; Parkman HP; Wilding GE; McCallum RW; Hasler WL; Kuo B
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1770-1779.e2. PubMed ID: 30557741
[TBL] [Abstract][Full Text] [Related]
9. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
[TBL] [Abstract][Full Text] [Related]
10. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
[TBL] [Abstract][Full Text] [Related]
11. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.
Gonenne J; Camilleri M; Ferber I; Burton D; Baxter K; Keyashian K; Foss J; Wallin B; Du W; Zinsmeister AR
Clin Gastroenterol Hepatol; 2005 Aug; 3(8):784-91. PubMed ID: 16234007
[TBL] [Abstract][Full Text] [Related]
12. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome.
Camilleri M; McKinzie S; Fox J; Foxx-Orenstein A; Burton D; Thomforde G; Baxter K; Zinsmeister AR
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):895-904. PubMed ID: 15476153
[TBL] [Abstract][Full Text] [Related]
13. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
Carbone F; Van den Houte K; Clevers E; Andrews CN; Papathanasopoulos A; Holvoet L; Van Oudenhove L; Caenepeel P; Arts J; Vanuytsel T; Tack J
Am J Gastroenterol; 2019 Aug; 114(8):1265-1274. PubMed ID: 31295161
[TBL] [Abstract][Full Text] [Related]
15. Prokinetic effects of mirtazapine on gastrointestinal transit.
Yin J; Song J; Lei Y; Xu X; Chen JD
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G796-801. PubMed ID: 24627566
[TBL] [Abstract][Full Text] [Related]
16. Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods.
Coleski R; Wilding GE; Semler JR; Hasler WL
PLoS One; 2015; 10(10):e0141183. PubMed ID: 26510137
[TBL] [Abstract][Full Text] [Related]
17. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women.
Gonenne J; Esfandyari T; Camilleri M; Burton DD; Stephens DA; Baxter KL; Zinsmeister AR; Bharucha AE
Neurogastroenterol Motil; 2006 Oct; 18(10):911-8. PubMed ID: 16961694
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis.
Abell TL; Kuo B; Esfandyari T; Pfeifer ND; Grimaldi M; Renzulli C; Tacchi R; Zhou K; Barnes CN; Nguyen DD; Nguyen L; Talley NJ; McCallum R
Neurogastroenterol Motil; 2023 Apr; 35(4):e14523. PubMed ID: 36624727
[TBL] [Abstract][Full Text] [Related]
19. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans.
Bouras EP; Camilleri M; Burton DD; McKinzie S
Gut; 1999 May; 44(5):682-6. PubMed ID: 10205205
[TBL] [Abstract][Full Text] [Related]
20. Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans.
Bharucha AE; Ravi K; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G215-9. PubMed ID: 20395537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
